🇺🇸 FDA
Patent

US 10780058

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

granted A61KA61K2300/00A61K31/355

Quick answer

US patent 10780058 (Nucleic acid nanocapsules for drug delivery and targeted gene knockdown) held by UNIVERSITY OF CONNECTICUT expires Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Sep 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2300/00, A61K31/355, A61K31/4188, A61K31/575